Category - Pharma Industry News
AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance
Avacta gets MHRA green-light to start phase I trial for ‘pro-drug’ chemotherapy
New social media campaign launched to support COVID-19 vaccine roll-out in the UK
Oxford University to develop Alzheimer’s disease treatments with Exscientia
GSK, Vir look beyond COVID-19 to develop new therapies for flu and other respiratory viruses
Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors
AZ/Merck & Co’s PARP inhibitor Lynparza scores trial win in early breast cancer
Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU